Jurga Sauvageot

3.0k total citations
17 papers, 2.0k citations indexed

About

Jurga Sauvageot is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Jurga Sauvageot has authored 17 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 3 papers in Rheumatology. Recurrent topics in Jurga Sauvageot's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Molecular Biology Techniques and Applications (5 papers). Jurga Sauvageot is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Molecular Biology Techniques and Applications (5 papers). Jurga Sauvageot collaborates with scholars based in United States and Germany. Jurga Sauvageot's co-authors include Jonathan I. Epstein, Charles M. Ewing, William B. Isaacs, H. Ballentine Carter, Jun Luo, Steven Piantadosi, David M. Steinberg, Yidong Chen, Jeffrey M. Trent and William B. Isaacs and has published in prestigious journals such as The Journal of Urology, American Journal Of Pathology and The American Journal of Surgical Pathology.

In The Last Decade

Jurga Sauvageot

17 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jurga Sauvageot United States 15 1.2k 778 338 321 294 17 2.0k
Jiangchun Xu United States 22 769 0.7× 1.2k 1.5× 651 1.9× 211 0.7× 429 1.5× 27 2.3k
Isabel Heidegger Austria 26 1.2k 1.0× 829 1.1× 554 1.6× 216 0.7× 553 1.9× 123 2.4k
Daniel Sudilovsky United States 15 509 0.4× 698 0.9× 250 0.7× 103 0.3× 623 2.1× 32 1.6k
Markku H. Vaarala Finland 22 552 0.5× 572 0.7× 220 0.7× 133 0.4× 286 1.0× 53 1.5k
Rosalie Nolley United States 23 1.0k 0.9× 814 1.0× 400 1.2× 171 0.5× 317 1.1× 55 2.0k
Tuomas Mirtti Finland 29 1.1k 0.9× 1.6k 2.1× 718 2.1× 76 0.2× 825 2.8× 127 3.0k
William B. Isaacs United States 24 797 0.7× 1.1k 1.4× 415 1.2× 70 0.2× 283 1.0× 41 2.0k
T. Ming Chu United States 24 849 0.7× 556 0.7× 139 0.4× 269 0.8× 625 2.1× 53 2.1k
Henning Reis Germany 33 825 0.7× 1.1k 1.4× 567 1.7× 121 0.4× 891 3.0× 182 3.1k
W. Grigioni Italy 24 642 0.5× 636 0.8× 604 1.8× 156 0.5× 725 2.5× 59 2.3k

Countries citing papers authored by Jurga Sauvageot

Since Specialization
Citations

This map shows the geographic impact of Jurga Sauvageot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurga Sauvageot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurga Sauvageot more than expected).

Fields of papers citing papers by Jurga Sauvageot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jurga Sauvageot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurga Sauvageot. The network helps show where Jurga Sauvageot may publish in the future.

Co-authorship network of co-authors of Jurga Sauvageot

This figure shows the co-authorship network connecting the top 25 collaborators of Jurga Sauvageot. A scholar is included among the top collaborators of Jurga Sauvageot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurga Sauvageot. Jurga Sauvageot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sfanos, Karen S., Jurga Sauvageot, Helen Fedor, et al.. (2007). A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. The Prostate. 68(3). 306–320. 174 indexed citations
2.
Liu, Wennuan, Bao‐Li Chang, Jurga Sauvageot, et al.. (2006). Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array. Genes Chromosomes and Cancer. 45(11). 1018–1032. 47 indexed citations
3.
Xu, Junyan, Jurga Sauvageot, Charles M. Ewing, et al.. (2006). GermlineATBF1 mutations and prostate cancer risk. The Prostate. 66(10). 1082–1085. 18 indexed citations
4.
Dunn, Thomas A., Shenglin Chen, Dennis Faith, et al.. (2006). A Novel Role of Myosin VI in Human Prostate Cancer. American Journal Of Pathology. 169(5). 1843–1854. 112 indexed citations
5.
Luo, Jun, Thomas A. Dunn, Charles M. Ewing, et al.. (2002). Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. The Prostate. 51(3). 189–200. 109 indexed citations
6.
Luo, Jun, David Duggan, Yidong Chen, et al.. (2001). Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.. PubMed. 61(12). 4683–8. 394 indexed citations
7.
Zha, Shan, Wesley R. Gage, Jurga Sauvageot, et al.. (2001). Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.. PubMed. 61(24). 8617–23. 218 indexed citations
8.
Ewing, Charles M., et al.. (2000). Detection and analysis of ?-catenin mutations in prostate cancer. The Prostate. 45(4). 323–334. 148 indexed citations
9.
Sauvageot, Jurga, et al.. (1998). Histology and Cellular Kinetics of Prostatic Atrophy. The American Journal of Surgical Pathology. 22(9). 1073–1077. 101 indexed citations
10.
Carter, H. Ballentine, Jurga Sauvageot, Patrick C. Walsh, & Jonathan I. Epstein. (1997). Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the Prostate. The Journal of Urology. 157(6). 2206–2209. 150 indexed citations
11.
Epstein, Jonathan I. & Jurga Sauvageot. (1997). Do Close but Negative Margins in Radical Prostatectomy Specimens Increase the Risk of Postoperative Progression?. The Journal of Urology. 241–243. 2 indexed citations
12.
Steinberg, David M., Jurga Sauvageot, Steven Piantadosi, & Jonathan I. Epstein. (1997). Correlation of Prostate Needle Biopsy and Radical Prostatectomy Gleason Grade in Academic and Community Settings. The American Journal of Surgical Pathology. 21(5). 566–576. 301 indexed citations
13.
Carter, H. Ballentine, Jurga Sauvageot, Patrick C. Walsh, & Jonathan I. Epstein. (1997). Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the Prostate. The Journal of Urology. 2206–2209. 2 indexed citations
14.
Epstein, Jonathan I., Patrick C. Walsh, Jurga Sauvageot, & H. Ballentine Carter. (1997). USE OF REPEAT SEXTANT AND TRANSITION ZONE BIOPSIES FOR ASSESSING EXTENT OF PROSTATE CANCER. The Journal of Urology. 158(5). 1886–1890. 161 indexed citations
15.
Epstein, Jonathan I. & Jurga Sauvageot. (1997). Do Close but Negative Margins in Radical Prostatectomy Specimens Increase the Risk of Postoperative Progression?. The Journal of Urology. 157(1). 241–243. 59 indexed citations
16.
Sanda, Martin G., Alan W. Partin, Jurga Sauvageot, et al.. (1996). Histopathologic characterization of hereditary benign prostatic hyperplasia. Urology. 48(4). 650–653. 22 indexed citations
17.
Sauvageot, Jurga, et al.. (1996). Cell proliferation and apoptosis in prostate cancer--correlation with pathologic stage?. PubMed. 9(3). 205–9. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026